CTOs on the Move

Fluresh

www.fluresh.com

 
Fluresh is a premium vertically integrated medical & adult use cannabis company obsessed with quality and wellness. We believe that each individual connection between a patient and cannabis is unique, dynamic and matchless.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.fluresh.com
  • 1213 Phillips Avenue SW
    Grand Rapids, MI USA 49507
  • Phone: 616.600.0420

Executives

Name Title Contact Details

Similar Companies

Image Owl

Image Owl creates complete, convenient , accurate and insightful cloud-based solutions to analyze and manage your diagnostic medical imaging and radiotherapy quality assurance needs.

Sundia MediTech Company

Sundia MediTech Company is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lawnwood Regional Medical Center and Heart Institute

Lawnwood Regional Medical Center and Heart Institute is a Fort Pierce, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Saint Luke Institute

Saint Luke Institute is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fresenius Kabi

Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.